Resources
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
URL
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00432-3/fulltext
Date of publication...
Safety and efficacy of a rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
To report preliminary results on the efficacy and safety of Gam-COVID-Vac from the interim analysis of this phase 3...
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial
They presented preliminary findings from a phase 2 trial on the immunogenicity and safety of BBV152, with the first dose...
COVID-19 optimal vaccination policies: A modeling study on efficacy, natural and vaccine-induced immunity responses
The goal of the study is to compare different vaccine profiles in order to compute optimal COVID-19 vaccination policies...
Public health impact of delaying the second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent-based modeling study
To estimate the population health outcomes of SARS-CoV-2 mRNA vaccination with a delayed second dose versus a standard...
The emergence of new strains of SARS-CoV-2. What does it mean for COVID-19 vaccines
This experts review article is based on various studies on the effectiveness of existing covid vaccines against new...
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study.
The aim was to assess the safety and immunogenicity of the BNT162b2 (Pfizer–BioNTech) vaccine in patients with...
Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study
To compare rates of cardiovascular and haemostatic events in Denmark and Norway in the first 28 days after vaccination...
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: a test-negative case-control study
To estimate the effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S vaccines against confirmed...
Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women
To assess the immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women, including the ability to protect...
COVID‑19 vaccines: rapid development, implications, challenges, and future prospects
In this review, they have discussed the various types of vaccines with examples of COVID-19 vaccines, their rapid...
Effects of different types of written vaccination information on COVID-19 vaccine hesitancy in the UK (OCEANS-III): a single-blind, parallel-group, randomised controlled trial
The study’s aim was to survey UK adults in order to estimate how many people would agree to be vaccinated against...